Home › Companies › Biogen Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Biogen Inc.’s Form 8-K, filed June 10, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of June 9, 2026: 12 items on Biogen Inc.’s Form 8-K, filed June 10, 2026: 2 approved · 10 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore Biogen Inc. in the interactive database Compare manager voting policies
These tallies are Biogen Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 10, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Maria C. Freire | 103,033,121 | 18,790,237 | 84,064 | -- | 9,359,127 | 85% | Not verified | — |
| Elect Director: William A. Hawkins | 102,135,204 | 19,683,098 | 89,120 | -- | 9,359,127 | 84% | Not verified | — |
| Elect Director: Susan K. Langer | 103,931,406 | 17,886,544 | 89,472 | -- | 9,359,127 | 85% | Not verified | — |
| Elect Director: Jesus B. Mantas | 101,698,187 | 20,117,077 | 92,158 | -- | 9,359,127 | 83% | Not verified | — |
| Elect Director: Lloyd Minor | 121,220,738 | 594,000 | 92,684 | -- | 9,359,127 | 99.5% | Not verified | — |
| Elect Director: Menelas Pangalos | 121,130,060 | 682,983 | 94,379 | -- | 9,359,127 | 99.4% | Not verified | — |
| Elect Director: Monish Patolawala | 120,796,249 | 1,016,057 | 95,116 | -- | 9,359,127 | 99.1% | Not verified | — |
| Elect Director: Eric K. Rowinsky | 93,569,685 | 28,216,589 | 121,148 | -- | 9,359,127 | 77% | Not verified | — |
| Elect Director: Stephen A. Sherwin | 103,025,923 | 18,788,272 | 93,227 | -- | 9,359,127 | 85% | Not verified | — |
| Elect Director: Christopher A. Viehbacher | 121,127,966 | 688,051 | 91,405 | -- | 9,359,127 | 99.4% | Not verified | — |
| 2. The selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, with the votes cast | 124,551,887 | 6,627,086 | 87,576 | -- | -- | 95% | Approved | — |
| 3. The advisory vote on executive compensation, with the votes cast | 114,184,816 | 7,454,737 | 267,869 | -- | 9,359,127 | 94% | Approved | — |
Source: Biogen Inc., Form 8-K, filed with the SEC on June 10, 2026 — read the filing on EDGAR.
Each item below shows how the 871 asset managers that disclosed a Biogen Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 8 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher
Biogen Inc.’s own tally for this item (“Elect Director: Christopher A. Viehbacher”): 121,127,966 for, 688,051 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 144 asset managers below reported 67,227,812 for, 44,093 against, 28,664 abstained, 175 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 30,906,047 | 30,740 | 1 | 0 | For |
| Fidelity | 14,004,646 | 0 | 0 | 0 | For |
| BlackRock | 6,103,317 | 2,444 | 0 | 0 | For |
| State Street | 2,210,739 | 3,679 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,861,140 | 0 | 0 | 0 | For |
| Invesco | 1,438,828 | 0 | 0 | 0 | For |
| Charles Schwab | 1,088,455 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,052,146 | 0 | 0 | 0 | For |
| John Hancock | 907,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 655,628 | 0 | 0 | 0 | For |
| First Trust | 632,967 | 0 | 0 | 0 | For |
| MFS | 529,991 | 0 | 0 | 0 | For |
| Dimensional | 430,461 | 0 | 0 | 0 | For |
| TIAA | 313,428 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 299,353 | 0 | 0 | 0 | For |
| Jackson National | 276,860 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 272,490 | 0 | 0 | 0 | For |
| JPMorgan | 263,339 | 0 | 0 | 0 | For |
| Victory Capital | 258,073 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 230,000 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 228,313 | 0 | 0 | 0 | For |
| Transamerica | 148,170 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 140,000 | 0 | 0 | 0 | For |
| Equitable | 122,472 | 0 | 0 | 0 | For |
| ALGER FUNDS | 120,383 | 0 | 0 | 0 | For |
Showing the 25 largest of 144 asset managers. See all 144 in the interactive database.
Combines 8 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky
Biogen Inc.’s own tally for this item (“Elect Director: Eric K. Rowinsky”): 93,569,685 for, 28,216,589 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 77% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 144 asset managers below reported 51,462,501 for, 15,780,674 against, 57,392 abstained, 175 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,643,533 | 12,293,253 | 1 | 0 | Mixed |
| Fidelity | 13,971,246 | 33,400 | 0 | 0 | For |
| BlackRock | 6,104,197 | 1,564 | 0 | 0 | For |
| State Street | 2,214,378 | 40 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 0 | 1,861,140 | 0 | 0 | Against |
| Invesco | 1,438,828 | 0 | 0 | 0 | For |
| Charles Schwab | 1,088,069 | 385 | 0 | 0 | For |
| T. Rowe Price | 663,310 | 388,836 | 0 | 0 | Mixed |
| John Hancock | 885,970 | 21,112 | 0 | 0 | For |
| Pacer Funds Trust | 655,628 | 0 | 0 | 0 | For |
| First Trust | 632,967 | 0 | 0 | 0 | For |
| MFS | 0 | 529,991 | 0 | 0 | Against |
| Dimensional | 430,461 | 0 | 0 | 0 | For |
| TIAA | 313,428 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 299,353 | 0 | 0 | 0 | For |
| Jackson National | 229,222 | 47,638 | 0 | 0 | Mixed |
| Bridge Builder Trust | 84,368 | 188,122 | 0 | 0 | Mixed |
| JPMorgan | 263,339 | 0 | 0 | 0 | For |
| Victory Capital | 258,073 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 230,000 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 228,313 | 0 | 0 | 0 | For |
| Transamerica | 148,170 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 140,000 | 0 | 0 | 0 | For |
| Equitable | 122,472 | 0 | 0 | 0 | For |
| ALGER FUNDS | 120,383 | 0 | 0 | 0 | For |
Showing the 25 largest of 144 asset managers. See all 144 in the interactive database.
Combines 8 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas
Biogen Inc.’s own tally for this item (“Elect Director: Jesus B. Mantas”): 101,698,187 for, 20,117,077 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 144 asset managers below reported 52,573,227 for, 14,722,676 against, 28,664 abstained, 175 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,632,722 | 12,304,063 | 1 | 0 | Mixed |
| Fidelity | 13,971,246 | 33,400 | 0 | 0 | For |
| BlackRock | 6,103,317 | 2,444 | 0 | 0 | For |
| State Street | 2,210,739 | 3,679 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 0 | 1,861,140 | 0 | 0 | Against |
| Invesco | 1,438,828 | 0 | 0 | 0 | For |
| Charles Schwab | 1,088,455 | 0 | 0 | 0 | For |
| T. Rowe Price | 663,310 | 388,836 | 0 | 0 | Mixed |
| John Hancock | 885,970 | 21,112 | 0 | 0 | For |
| Pacer Funds Trust | 655,628 | 0 | 0 | 0 | For |
| First Trust | 632,967 | 0 | 0 | 0 | For |
| MFS | 529,991 | 0 | 0 | 0 | For |
| Dimensional | 430,461 | 0 | 0 | 0 | For |
| TIAA | 313,428 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 299,353 | 0 | 0 | 0 | For |
| Jackson National | 276,760 | 100 | 0 | 0 | For |
| Bridge Builder Trust | 203,968 | 68,522 | 0 | 0 | Mixed |
| JPMorgan | 263,339 | 0 | 0 | 0 | For |
| Victory Capital | 258,073 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 230,000 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 228,313 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 164,000 | 0 | 0 | 0 | For |
| Transamerica | 148,170 | 0 | 0 | 0 | For |
| Equitable | 122,472 | 0 | 0 | 0 | For |
| ALGER FUNDS | 120,383 | 0 | 0 | 0 | For |
Showing the 25 largest of 144 asset managers. See all 144 in the interactive database.
Combines 9 wordings of this item as funds reported it.
99.5% Majority: yes · of votes cast
Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Lloyd Minor
Biogen Inc.’s own tally for this item (“Elect Director: Lloyd Minor”): 121,220,738 for, 594,000 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 144 asset managers below reported 67,268,088 for, 3,816 against, 28,664 abstained, 175 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 30,936,775 | 11 | 1 | 0 | For |
| Fidelity | 14,004,646 | 0 | 0 | 0 | For |
| BlackRock | 6,105,761 | 0 | 0 | 0 | For |
| State Street | 2,214,418 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,861,140 | 0 | 0 | 0 | For |
| Invesco | 1,438,828 | 0 | 0 | 0 | For |
| Charles Schwab | 1,088,455 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,052,146 | 0 | 0 | 0 | For |
| John Hancock | 907,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 655,628 | 0 | 0 | 0 | For |
| First Trust | 632,967 | 0 | 0 | 0 | For |
| MFS | 529,991 | 0 | 0 | 0 | For |
| Dimensional | 430,461 | 0 | 0 | 0 | For |
| TIAA | 313,428 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 299,353 | 0 | 0 | 0 | For |
| Jackson National | 276,860 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 272,490 | 0 | 0 | 0 | For |
| JPMorgan | 263,339 | 0 | 0 | 0 | For |
| Victory Capital | 258,073 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 230,000 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 228,313 | 0 | 0 | 0 | For |
| Transamerica | 148,170 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 140,000 | 0 | 0 | 0 | For |
| Equitable | 122,472 | 0 | 0 | 0 | For |
| ALGER FUNDS | 120,383 | 0 | 0 | 0 | For |
Showing the 25 largest of 144 asset managers. See all 144 in the interactive database.
Combines 7 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire
Biogen Inc.’s own tally for this item (“Elect Director: Maria C. Freire”): 103,033,121 for, 18,790,237 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 144 asset managers below reported 52,973,294 for, 14,322,611 against, 28,664 abstained, 175 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,632,740 | 12,304,047 | 1 | 0 | Mixed |
| Fidelity | 14,004,646 | 0 | 0 | 0 | For |
| BlackRock | 6,103,317 | 2,444 | 0 | 0 | For |
| State Street | 2,210,739 | 3,679 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 0 | 1,861,140 | 0 | 0 | Against |
| Invesco | 1,438,828 | 0 | 0 | 0 | For |
| Charles Schwab | 1,088,455 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,052,146 | 0 | 0 | 0 | For |
| John Hancock | 907,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 655,628 | 0 | 0 | 0 | For |
| First Trust | 632,967 | 0 | 0 | 0 | For |
| MFS | 529,991 | 0 | 0 | 0 | For |
| Dimensional | 430,461 | 0 | 0 | 0 | For |
| TIAA | 313,428 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 299,353 | 0 | 0 | 0 | For |
| Jackson National | 276,860 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 272,490 | 0 | 0 | 0 | For |
| JPMorgan | 263,339 | 0 | 0 | 0 | For |
| Victory Capital | 258,073 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 230,000 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 228,313 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 164,000 | 0 | 0 | 0 | For |
| Transamerica | 148,170 | 0 | 0 | 0 | For |
| Equitable | 122,472 | 0 | 0 | 0 | For |
| ALGER FUNDS | 120,383 | 0 | 0 | 0 | For |
Showing the 25 largest of 144 asset managers. See all 144 in the interactive database.
Combines 8 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Menelas Pangalos
Biogen Inc.’s own tally for this item (“Elect Director: Menelas Pangalos”): 121,130,060 for, 682,983 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 144 asset managers below reported 67,266,997 for, 4,907 against, 28,664 abstained, 175 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 30,936,773 | 13 | 1 | 0 | For |
| Fidelity | 14,004,646 | 0 | 0 | 0 | For |
| BlackRock | 6,105,761 | 0 | 0 | 0 | For |
| State Street | 2,214,418 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,861,140 | 0 | 0 | 0 | For |
| Invesco | 1,438,828 | 0 | 0 | 0 | For |
| Charles Schwab | 1,088,455 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,052,146 | 0 | 0 | 0 | For |
| John Hancock | 907,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 655,628 | 0 | 0 | 0 | For |
| First Trust | 632,967 | 0 | 0 | 0 | For |
| MFS | 529,991 | 0 | 0 | 0 | For |
| Dimensional | 430,461 | 0 | 0 | 0 | For |
| TIAA | 313,428 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 299,353 | 0 | 0 | 0 | For |
| Jackson National | 276,860 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 272,490 | 0 | 0 | 0 | For |
| JPMorgan | 263,339 | 0 | 0 | 0 | For |
| Victory Capital | 258,073 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 230,000 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 228,313 | 0 | 0 | 0 | For |
| Transamerica | 148,170 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 140,000 | 0 | 0 | 0 | For |
| Equitable | 122,472 | 0 | 0 | 0 | For |
| ALGER FUNDS | 120,383 | 0 | 0 | 0 | For |
Showing the 25 largest of 144 asset managers. See all 144 in the interactive database.
Combines 8 wordings of this item as funds reported it.
99.1% Majority: yes · of votes cast
Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala
Biogen Inc.’s own tally for this item (“Elect Director: Monish Patolawala”): 120,796,249 for, 1,016,057 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.1% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 144 asset managers below reported 67,268,082 for, 3,821 against, 28,664 abstained, 175 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 30,936,769 | 16 | 1 | 0 | For |
| Fidelity | 14,004,646 | 0 | 0 | 0 | For |
| BlackRock | 6,105,761 | 0 | 0 | 0 | For |
| State Street | 2,214,418 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,861,140 | 0 | 0 | 0 | For |
| Invesco | 1,438,828 | 0 | 0 | 0 | For |
| Charles Schwab | 1,088,455 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,052,146 | 0 | 0 | 0 | For |
| John Hancock | 907,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 655,628 | 0 | 0 | 0 | For |
| First Trust | 632,967 | 0 | 0 | 0 | For |
| MFS | 529,991 | 0 | 0 | 0 | For |
| Dimensional | 430,461 | 0 | 0 | 0 | For |
| TIAA | 313,428 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 299,353 | 0 | 0 | 0 | For |
| Jackson National | 276,860 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 272,490 | 0 | 0 | 0 | For |
| JPMorgan | 263,339 | 0 | 0 | 0 | For |
| Victory Capital | 258,073 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 230,000 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 228,313 | 0 | 0 | 0 | For |
| Transamerica | 148,170 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 140,000 | 0 | 0 | 0 | For |
| Equitable | 122,472 | 0 | 0 | 0 | For |
| ALGER FUNDS | 120,383 | 0 | 0 | 0 | For |
Showing the 25 largest of 144 asset managers. See all 144 in the interactive database.
Combines 8 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin
Biogen Inc.’s own tally for this item (“Elect Director: Stephen A. Sherwin”): 103,025,923 for, 18,788,272 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 144 asset managers below reported 53,131,048 for, 14,140,856 against, 28,664 abstained, 175 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,663,461 | 12,273,325 | 1 | 0 | Mixed |
| Fidelity | 14,004,646 | 0 | 0 | 0 | For |
| BlackRock | 6,105,761 | 0 | 0 | 0 | For |
| State Street | 2,214,378 | 40 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 0 | 1,861,140 | 0 | 0 | Against |
| Invesco | 1,438,828 | 0 | 0 | 0 | For |
| Charles Schwab | 1,088,455 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,052,146 | 0 | 0 | 0 | For |
| John Hancock | 907,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 655,628 | 0 | 0 | 0 | For |
| First Trust | 632,967 | 0 | 0 | 0 | For |
| MFS | 529,991 | 0 | 0 | 0 | For |
| Dimensional | 430,461 | 0 | 0 | 0 | For |
| TIAA | 313,428 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 299,353 | 0 | 0 | 0 | For |
| Jackson National | 276,860 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 272,490 | 0 | 0 | 0 | For |
| JPMorgan | 263,339 | 0 | 0 | 0 | For |
| Victory Capital | 258,073 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 230,000 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 228,313 | 0 | 0 | 0 | For |
| Transamerica | 148,170 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 140,000 | 0 | 0 | 0 | For |
| Equitable | 122,472 | 0 | 0 | 0 | For |
| ALGER FUNDS | 120,383 | 0 | 0 | 0 | For |
Showing the 25 largest of 144 asset managers. See all 144 in the interactive database.
Combines 8 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer
Biogen Inc.’s own tally for this item (“Elect Director: Susan K. Langer”): 103,931,406 for, 17,886,544 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 144 asset managers below reported 52,332,333 for, 14,963,571 against, 28,664 abstained, 175 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,663,474 | 12,273,312 | 1 | 0 | Mixed |
| Fidelity | 13,971,246 | 33,400 | 0 | 0 | For |
| BlackRock | 6,105,761 | 0 | 0 | 0 | For |
| State Street | 2,214,418 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 0 | 1,861,140 | 0 | 0 | Against |
| Invesco | 1,438,828 | 0 | 0 | 0 | For |
| Charles Schwab | 1,088,455 | 0 | 0 | 0 | For |
| T. Rowe Price | 663,310 | 388,836 | 0 | 0 | Mixed |
| John Hancock | 885,970 | 21,112 | 0 | 0 | For |
| Pacer Funds Trust | 655,628 | 0 | 0 | 0 | For |
| First Trust | 632,967 | 0 | 0 | 0 | For |
| MFS | 529,991 | 0 | 0 | 0 | For |
| Dimensional | 430,461 | 0 | 0 | 0 | For |
| TIAA | 313,428 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 299,353 | 0 | 0 | 0 | For |
| Jackson National | 276,760 | 100 | 0 | 0 | For |
| Bridge Builder Trust | 203,968 | 68,522 | 0 | 0 | Mixed |
| JPMorgan | 0 | 263,339 | 0 | 0 | Against |
| Victory Capital | 258,073 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 230,000 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 228,313 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 164,000 | 0 | 0 | 0 | For |
| Transamerica | 148,170 | 0 | 0 | 0 | For |
| Equitable | 105,662 | 16,810 | 0 | 0 | Mixed |
| ALGER FUNDS | 120,383 | 0 | 0 | 0 | For |
Showing the 25 largest of 144 asset managers. See all 144 in the interactive database.
Combines 8 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: Election of Directors. To elect the 10 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2027 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins
Biogen Inc.’s own tally for this item (“Elect Director: William A. Hawkins”): 102,135,204 for, 19,683,098 against, per its Form 8-K filed June 10, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 144 asset managers below reported 52,457,791 for, 14,838,114 against, 28,664 abstained, 175 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 18,632,714 | 12,304,073 | 1 | 0 | Mixed |
| Fidelity | 14,004,646 | 0 | 0 | 0 | For |
| BlackRock | 6,103,317 | 2,444 | 0 | 0 | For |
| State Street | 2,210,739 | 3,679 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 0 | 1,861,140 | 0 | 0 | Against |
| Invesco | 1,438,828 | 0 | 0 | 0 | For |
| Charles Schwab | 1,088,455 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,052,146 | 0 | 0 | 0 | For |
| John Hancock | 907,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 655,628 | 0 | 0 | 0 | For |
| First Trust | 632,967 | 0 | 0 | 0 | For |
| MFS | 0 | 529,991 | 0 | 0 | Against |
| Dimensional | 430,461 | 0 | 0 | 0 | For |
| TIAA | 313,428 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 299,353 | 0 | 0 | 0 | For |
| Jackson National | 229,322 | 47,538 | 0 | 0 | Mixed |
| Bridge Builder Trust | 272,490 | 0 | 0 | 0 | For |
| JPMorgan | 263,339 | 0 | 0 | 0 | For |
| Victory Capital | 258,073 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 230,000 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 228,313 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 164,000 | 0 | 0 | 0 | For |
| Transamerica | 148,170 | 0 | 0 | 0 | For |
| Equitable | 122,472 | 0 | 0 | 0 | For |
| ALGER FUNDS | 120,383 | 0 | 0 | 0 | For |
Showing the 25 largest of 144 asset managers. See all 144 in the interactive database.
Combines 5 wordings of this item as funds reported it.
94% Approved · of votes cast
Description as filed by funds: Say on Pay - To hold an advisory vote on executive compensation.
Biogen Inc.’s own tally for this item (“3. The advisory vote on executive compensation, with the votes cast”): 114,184,816 for, 7,454,737 against — passed, per its Form 8-K filed June 10, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders approved the advisory vote on executive compensation, with the votes cast as follows:”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Biogen Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (30 managers, Fund and manager reports combined; may count the same shares twice; no share total shown); “14A Executive Compensation” (16 managers, 69,871 for, 20 abstained, 1,501 not voted).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 30,936,650 | 133 | 4 | 0 | For |
| Fidelity | 14,004,646 | 0 | 0 | 0 | For |
| BlackRock | 6,105,761 | 0 | 0 | 0 | For |
| State Street | 2,214,418 | 0 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,861,140 | 0 | 0 | 0 | For |
| Invesco | 1,438,828 | 0 | 0 | 0 | For |
| Charles Schwab | 1,088,455 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,052,146 | 0 | 0 | 0 | For |
| John Hancock | 907,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 655,628 | 0 | 0 | 0 | For |
| First Trust | 632,967 | 0 | 0 | 0 | For |
| MFS | 529,991 | 0 | 0 | 0 | For |
| Dimensional | 430,461 | 0 | 0 | 0 | For |
| TIAA | 313,428 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 299,353 | 0 | 0 | 0 | For |
| Jackson National | 276,860 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 272,490 | 0 | 0 | 0 | For |
| JPMorgan | 263,339 | 0 | 0 | 0 | For |
| Victory Capital | 258,073 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 230,000 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 228,313 | 0 | 0 | 0 | For |
| Transamerica | 148,170 | 0 | 0 | 0 | For |
| Equitable | 122,472 | 0 | 0 | 0 | For |
| ALGER FUNDS | 120,383 | 0 | 0 | 0 | For |
| Six Circles Trust | 113,705 | 0 | 0 | 0 | For |
Fund voting reports, all 135 managers: 66,839,009 for, 151,251 against, 32,472 abstained, 176 not voted. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ | 14,700,777 | 0 | 0 | 0 | For |
| Fidelity | 12,487,008 | 318,602 | 0 | 0 | For |
| BlackRock | 7,169,141 | 430 | 0 | 0 | For |
| State Street | 4,819,142 | 12,821 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 4,377,494 | 0 | 0 | 0 | For |
| Wellington | 3,091,383 | 0 | 0 | 0 | For |
| T. Rowe Price | 2,201,341 | 0 | 0 | 0 | For |
| Invesco | 1,662,435 | 0 | 0 | 0 | For |
| Vanguard | 1,523,320 | 0 | 0 | 0 | For |
| Northern Trust | 1,251,034 | 0 | 0 | 0 | For |
| Amundi | 0 | 1,210,058 | 0 | 0 | Against |
| Boston Partners | 1,149,147 | 0 | 0 | 0 | For |
| Charles Schwab | 1,137,768 | 0 | 0 | 0 | For |
| AQR | 946,301 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 929,361 | 0 | 0 | 0 | For |
| Robeco Institutional Asset Management B.V. | 874,036 | 0 | 0 | 0 | For |
| UBS | 819,098 | 0 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 14,300 | 780,951 | 0 | 0 | Against |
| PICTET ASSET MANAGEMENT SA | 781,207 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 770,223 | 0 | 0 | 0 | For |
| FRED ALGER MANAGEMENT, LLC | 770,050 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 745,324 | 0 | 0 | 0 | For |
| Goldman Sachs | 590,134 | 0 | 0 | 0 | For |
| Legal & General Investment Management America Inc | 0 | 553,563 | 0 | 0 | Against |
| Artemis Investment Management LLP | 545,246 | 0 | 0 | 0 | For |
Institutional-manager reports, all 728 managers: 75,449,559 for, 5,541,153 against, 145,819 abstained, 21,257 not voted. Showing the 25 largest; see all in the interactive database.
Combines 4 wordings of this item as funds reported it.
95% Approved · of votes cast
Description as filed by funds: To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2026.
Biogen Inc.’s own tally for this item (“2. The selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, with the votes cast”): 124,551,887 for, 6,627,086 against — passed, per its Form 8-K filed June 10, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, with the votes cast as follows:”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Biogen Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (4 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).
The 141 asset managers below reported 67,047,950 for, 24,895 against, 28,664 abstained, 175 not voted.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 30,916,912 | 19,877 | 1 | 0 | For |
| Fidelity | 14,004,646 | 0 | 0 | 0 | For |
| BlackRock | 6,104,943 | 818 | 0 | 0 | For |
| State Street | 2,214,378 | 40 | 0 | 0 | For |
| PRIMECAP Odyssey Funds | 1,861,140 | 0 | 0 | 0 | For |
| Invesco | 1,438,828 | 0 | 0 | 0 | For |
| Charles Schwab | 1,088,455 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,052,146 | 0 | 0 | 0 | For |
| John Hancock | 907,082 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 655,628 | 0 | 0 | 0 | For |
| First Trust | 632,967 | 0 | 0 | 0 | For |
| MFS | 529,991 | 0 | 0 | 0 | For |
| Dimensional | 430,461 | 0 | 0 | 0 | For |
| TIAA | 313,428 | 0 | 0 | 0 | For |
| ALGER INSTITUTIONAL FUNDS | 299,353 | 0 | 0 | 0 | For |
| Jackson National | 276,860 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 272,490 | 0 | 0 | 0 | For |
| JPMorgan | 263,339 | 0 | 0 | 0 | For |
| Victory Capital | 258,073 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 230,000 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 228,313 | 0 | 0 | 0 | For |
| Transamerica | 148,170 | 0 | 0 | 0 | For |
| Equitable | 122,472 | 0 | 0 | 0 | For |
| ALGER FUNDS | 120,383 | 0 | 0 | 0 | For |
| Six Circles Trust | 113,705 | 0 | 0 | 0 | For |
Showing the 25 largest of 141 asset managers. See all 141 in the interactive database.
Not shown here: this season’s fund filings also report 1 item from the meeting of June 17, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 146,800,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 21.07% |
| 2 | Fidelity | 9.54% |
| 3 | BlackRock | 4.16% |
| 4 | State Street | 1.51% |
| 5 | PRIMECAP Odyssey Funds | 1.27% |
| 6 | Invesco | 0.98% |
| 7 | Charles Schwab | 0.74% |
| 8 | T. Rowe Price | 0.72% |
| 9 | John Hancock | 0.62% |
| 10 | Pacer Funds Trust | 0.45% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | PRIMECAP MANAGEMENT CO/CA/ | 10.01% |
| 2 | Fidelity | 8.72% |
| 3 | BlackRock | 4.88% |
| 4 | State Street | 3.29% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.98% |
| 6 | Wellington | 2.11% |
| 7 | T. Rowe Price | 1.50% |
| 8 | Invesco | 1.13% |
| 9 | Vanguard | 1.04% |
| 10 | Northern Trust | 0.85% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 10.88% | 13F |
| FMR (Fidelity) | 8.72% | 13F |
| State Street | 4.88% | 13F |
| Wellington Management | 2.02% | 13F |
| Morgan Stanley | 1.58% | 13F |
| JPMorgan Chase | 1.37% | 13F |
| Invesco | 1.19% | 13F |
Percentages above are of 146,800,000 shares outstanding, as reported by Biogen Inc. on its Form 10-K dated December 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Biogen Inc.’s 10-K dated December 31, 2025. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At Biogen Inc.'s shareholder meeting held June 9, 2026, in the 2025-2026 proxy season, 871 asset managers reported how they voted on 12 ballot items in their SEC Form N-PX filings, covering 11,051 separate fund positions. On the most widely held item on that ballot — Say on Pay - To hold an advisory vote on executive compensation. — Biogen Inc.'s filing reports the proposal as approved, with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Biogen Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 10, 2026.
Biogen Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.